bet365 au

bet365 au

Miles to go: on one year of the Congress government in TelanganaConnor Clark & Lunn Investment Management Ltd. increased its holdings in shares of Option Care Health, Inc. ( NASDAQ:OPCH – Free Report ) by 438.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 145,257 shares of the company’s stock after buying an additional 118,292 shares during the period. Connor Clark & Lunn Investment Management Ltd. owned 0.09% of Option Care Health worth $4,547,000 at the end of the most recent quarter. Several other large investors have also bought and sold shares of the business. CANADA LIFE ASSURANCE Co lifted its stake in shares of Option Care Health by 1.8% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 134,305 shares of the company’s stock valued at $4,503,000 after purchasing an additional 2,355 shares during the period. CreativeOne Wealth LLC lifted its stake in Option Care Health by 24.9% in the first quarter. CreativeOne Wealth LLC now owns 10,885 shares of the company’s stock valued at $365,000 after buying an additional 2,173 shares during the period. BOKF NA boosted its holdings in Option Care Health by 13.5% during the first quarter. BOKF NA now owns 47,139 shares of the company’s stock worth $1,546,000 after buying an additional 5,589 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Option Care Health by 1.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,760,482 shares of the company’s stock worth $59,047,000 after buying an additional 23,676 shares during the period. Finally, Janus Henderson Group PLC increased its stake in shares of Option Care Health by 182.9% in the 1st quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock valued at $7,617,000 after acquiring an additional 146,837 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds. Option Care Health Trading Up 2.8 % OPCH opened at $23.13 on Friday. The stock has a market capitalization of $3.94 billion, a P/E ratio of 19.44, a P/E/G ratio of 2.33 and a beta of 1.32. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63. The firm’s fifty day simple moving average is $27.62 and its 200 day simple moving average is $29.10. Insider Activity Analysts Set New Price Targets Several research firms recently weighed in on OPCH. Barrington Research reduced their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. JMP Securities lifted their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Truist Financial lowered their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and reduced their target price for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Finally, Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Option Care Health has a consensus rating of “Moderate Buy” and an average price target of $30.83. View Our Latest Stock Report on Option Care Health Option Care Health Profile ( Free Report ) Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. Featured Stories Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. ( NASDAQ:OPCH – Free Report ). Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter .Zomato chief executive office (CEO) Deepinder Goyal's recent post listing the criteria for hiring a chief of staff went viral-largely due to the wrong reasons. The social media uproar over the issue of the candidate paying ₹20 lakh to the company and drawing no compensation for a year prompted Goyal to reveal that the requirement to pay ₹20 lakh was just a filter to find the right candidate. It is the second time that the CEO had to issue a retracting statement. Earlier in March, Zomato rolled back its plan to colour code its veg fleet following social media backlash to Goyal's previous day's announcement of the plan. Changing decisions based on social media reaction may appear to be a sign of a responsive management, but repeated instances may create a perception that undermines the decision-making of the top management. It may also attract regulatory scrutiny stock valuation is impacted. Last month, a social media spat involving Ola Electric's CEO and a standup comedian shaved off over ₹7,000 crore from the market cap of the electric vehicle company. The Ola stock is now trading below the IPO offer price. Digital payments platform Paytm recently issued an apology on X for a controversial post made by its CEO Vijay Shekhar Sharma on the demise of Tata group veteran Ratan Tata. Artificial Intelligence(AI) Master in Python Language Quickly Using the ChatGPT Open AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance Financial Literacy for Non-Finance Executives By - CA Raja, Chartered Accountant | Financial Management Educator | Former AVP - Credit, SBI View Program Finance Tally Prime & GST Accounting: Complete Guide By - CA Raj K Agrawal, Chartered Accountant View Program Web Development Advanced Java Mastery: Object-Oriented Programming Techniques By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) ChatGPT Mastery from Zero to Hero: The Complete AI Course By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Intermediate Java Mastery: Method, Collections, and Beyond By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Performance Marketing for eCommerce Brands By - Zafer Mukeri, Founder- Inara Marketers View Program Leadership Building Your Winning Startup Team: Key Strategies for Success By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Web Development JavaScript Essentials: Unlock AI-Driven Insights with ChatGPT By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development A Comprehensive ASP.NET Core MVC 6 Project Guide for 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance A2Z Of Money By - elearnmarkets, Financial Education by StockEdge View Program Data Science SQL for Data Science along with Data Analytics and Data Visualization By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance Crypto & NFT Mastery: From Basics to Advanced By - CA Raj K Agrawal, Chartered Accountant View Program Finance Financial Literacy i.e Lets Crack the Billionaire Code By - CA Rahul Gupta, CA with 10+ years of experience and Accounting Educator View Program Web Development C++ Fundamentals for Absolute Beginners By - Metla Sudha Sekhar, IT Specialist and Developer View Program Data Science SQL Server Bootcamp 2024: Transform from Beginner to Pro By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Advanced Excel Course - Financial Calculations & Excel Made Easy By - Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant View Program Marketing Modern Marketing Masterclass by Seth Godin By - Seth Godin, Former dot com Business Executive and Best Selling Author View Program Web Development Django & PostgreSQL Mastery: Build Professional Web Applications By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Future of Marketing & Branding Masterclass By - Dr. David Aaker, Professor Emeritus at the Haas School of Business, UC Berkeley, Author | Speaker | Thought Leader | Branding Consultant View Program Finance AI and Generative AI for Finance By - Hariom Tatsat, Vice President- Quantitative Analytics at Barclays View Program Leadership Crafting a Powerful Startup Value Proposition By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Artificial Intelligence(AI) Mastering C++ Fundamentals with Generative AI: A Hands-On By - Metla Sudha Sekhar, IT Specialist and Developer View Program Data Science MySQL for Beginners: Learn Data Science and Analytics Skills By - Metla Sudha Sekhar, IT Specialist and Developer View Program While Zerodha isn't listed, its co-founder Nikhil Kamath got trolled on social media for buying a house after years of advocating renting a house instead of buying one. To be sure, social media is largely unforgiving in calling out discrepancies. When CEOs are involved in an online dispute or controversy, the issue hardly remains restricted to them and has an adverse spillover effect on the company's reputation. While most large companies have a social media policy for their employees, young CEOs of newly listed companies tend to be more exuberant in their social media communication. It may be argued that any publicity is good publicity for the company and its brand, but repeated controversial posts from a CEO of a listed company may not go down well with the company's board of directors and institutional investors. The risk management committee of the board of directors may not be happy having the additional task of monitoring the social media conduct of CEOs. (You can now subscribe to our Economic Times WhatsApp channel )

EU's new universal charger rule aims to reduce waste

(Reuters) - Chipmaker Marvell Technology forecast fourth-quarter revenue above estimates on Tuesday, betting on robust demand for its custom artificial intelligence chips from businesses adopting booming generative AI technology. Shares of the Santa Clara, California-based company rose more than 8% in extended trading following the results. The stock hit a record high during Tuesday's trading session. Marvell's shares have risen nearly 60% this year as Wall Street pours billions of dollars into AI-linked stocks, placing huge bets on the future of genAI technology. Shares of larger competitor Broadcom have rallied about 50% this year. Demand for advanced chips that can support the complex processing needs of genAI has soared as companies race each other to develop the most sophisticated models. The company forecast fourth-quarter revenue of $1.80 billion, plus or minus 5%, compared with analysts' average estimate of $1.65 billion, according to data compiled by LSEG. While the market for AI processors is dominated by Nvidia, Big Tech has been vying to reduce its dependence on the chip leader's supply-constrained semiconductors, which has helped companies such as Marvell. Marvell said on Monday it had expanded its partnership with Amazon.com and entered into a five-year agreement with the tech giant's cloud unit, which includes supplying custom AI products. Revenue in Marvell's data center segment grew 98% to $1.10 billion in the third quarter from a year ago. Its total quarterly revenue was $1.52 billion, beating estimates of $1.46 billion. The company expects its AI revenue to triple to more than $1.5 billion this year and hit $2.5 billion for the next fiscal year, CEO Matt Murphy had said at a company event in April. Revenue derived from custom AI chips alone could be between $2.5 billion and $3 billion in 2025 for Marvell, with optical equipment adding another $1.5 billion to $2 billion to AI revenue, Jefferies analysts had said in a note in October. On the other hand, customers in the company's other end-markets such as wireless carriers have been working to drive down chip inventory after excessive buying during the pandemic resulted in a supply glut. Marvell forecast an adjusted gross margin of 60% for the fourth quarter, compared with estimates of 61%. A significant share of Marvell's revenue is now derived from custom AI chips as AI-linked demand rises. The company's custom chips typically carry lower margins than its off-the-shelf products, known as merchant products. Marvell's enterprise networking segment posted a 44% fall to $150.9 million in revenue, while that of the company's carrier infrastructure unit declined 73% to $84.7 million. The company recorded adjusted earnings of 43 cents per share in the third quarter, compared with estimates of 41 cents. (Reporting by Arsheeya Bajwa and Abhinav Parmar in Bengaluru; Editing by Shreya Biswas) Copyright 2024 Thomson Reuters .U.S. ahead in AI innovation, easily surpassing China in Stanford's new ranking

Cameras Catch Travis Kelce's Frustrated Reaction After Failed Play With Patrick MahomesPhiladelphia (8-2) at Los Angeles Rams (5-5) Sunday, 8:20 p.m. EST, NBC/Peacock